title: [Effects of HGF on GVHD and Th1/Th2-related cytokines in ALL mice after allo-BMT].
abstract: To observe the effects of hepatocyte growth factor (HGF) on graft-versus-host disease (GVHD) and Th1/Th2 related cytokines in mice with acute lymphoblastic leukemia (ALL) after allogenic bone marrow transplantation (allo-BMT), BALB/c mice were conditioned by total body irradiation with 11 Gy and then were transplanted with allogeneic bone marrow after establishing ALL model. BALB/c mice were divided into groups A and B. The mice of group A were injected subcutaneously with HGF from day 0 to 7 after allo-BMT, and the mice of group B were injected subcutaneously with PBS from day 0 to 7 after allo-BMT. The symptoms of GVHD and the GVHD pathological changes of liver and small intestine and skin were observed. The serum levels of both IFN-gamma and IL-4 were determined by ELISA. The results showed that the score of GVHD in group A was lower than that in group B (P < 0.05). The levels of IFN-gamma in both groups A and B were all higher than that in normal group (P < 0.05 and P < 0.001, respectively), However, the level of IFN-gamma in group A was lower than that in group B (P < 0.01). The levels of IL-4 in both group A and B were all lower than that in normal group (P < 0.05), but the level of IL-4 in group A was higher than that in group B (P < 0.05). It is concluded that HGF can alleviates the severity of GVHD, because of its balancing the Th1/Th2-related cytokines after allo-BMT.
authors.affiliation: Department of Hematology, Taihe Hospital of Yunyang Medical College, Shiyan 442000, China. xiayunjin@163.com
authors.forename: Yun-Jin
authors.initials: YJ
authors.lastname: Xia
authors.forename: Qing-Ping
authors.initials: QP
authors.lastname: Gao
authors.forename: Chu-Cheng
authors.initials: CC
authors.lastname: Wan
authors.forename: Fan-Jun
authors.initials: FJ
authors.lastname: Cheng
authors.forename: Wei-Min
authors.initials: WM
authors.lastname: Wang
authors.forename: Ren-Ci
authors.initials: RC
authors.lastname: Guo
mesh_terms: D000818:Animals; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000379:methods*; D016207:Cytokines / Q000097:blood*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006086:Graft vs Host Disease / Q000276:immunology / Q000517:prevention & control*; D017228:Hepatocyte Growth Factor / Q000494:pharmacology*; D007371:Interferon-gamma / Q000097:blood; D015847:Interleukin-4 / Q000097:blood; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood / Q000276:immunology / Q000601:surgery*; D018417:Th1 Cells / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology; D014184:Transplantation, Homologous
chemical_list: D016207:Cytokines; D015847:Interleukin-4; D017228:Hepatocyte Growth Factor; D007371:Interferon-gamma